METHYLDOPATE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methyldopate Hydrochloride patents expire, and when can generic versions of Methyldopate Hydrochloride launch?
Methyldopate Hydrochloride is a drug marketed by Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral. and is included in ten NDAs.
The generic ingredient in METHYLDOPATE HYDROCHLORIDE is methyldopate hydrochloride. There are three drug master file entries for this compound. Additional details are available on the methyldopate hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYLDOPATE HYDROCHLORIDE?
- What are the global sales for METHYLDOPATE HYDROCHLORIDE?
- What is Average Wholesale Price for METHYLDOPATE HYDROCHLORIDE?
Summary for METHYLDOPATE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Patent Applications: | 163 |
| DailyMed Link: | METHYLDOPATE HYDROCHLORIDE at DailyMed |
US Patents and Regulatory Information for METHYLDOPATE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 070652-001 | Jun 3, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 070849-001 | Jun 19, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 070691-001 | Jun 19, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
